Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals | Small Cap
Health Score : 6.69Neogen Chemicals Ltd presents a mixed financial profile. The company's primary strengths are its excellent profitability and strong solvency, indicating it manages long-term debt prudently and effectively converts revenue into profit. This suggests a low long-term financial risk. However, there are significant areas of concern. The company's operational efficiency is weak, struggling with slow inventory movement and delayed collections from customers, which ties up cash. While revenue and assets are growing, this expansion has not translated into increased net income for shareholders, which has been declining. Short-term liquidity is also strained, with low cash levels to cover immediate obligations. The company is investing heavily for the future, but these investments are currently pressuring its financial performance.
Health Score : 6.69Neogen Chemicals Ltd presents a mixed financial profile. The company's primary strengths are its excellent profitability and strong solvency, indicating it manages long-term debt prudently and effectively converts revenue into profit. This suggests a low long-term financial risk. However, there are significant areas of concern. The company's operational efficiency is weak, struggling with slow inventory movement and delayed collections from customers, which ties up cash. While revenue and assets are growing, this expansion has not translated into increased net income for shareholders, which has been declining. Short-term liquidity is also strained, with low cash levels to cover immediate obligations. The company is investing heavily for the future, but these investments are currently pressuring its financial performance.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
125.59
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
197.61
P/B RATIO
6.97
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
6.85
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
-116.24
EV/EBITDA RATIO
47.09
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2153.9 as on Sep 1, 2026.
Growth Score : 6.00The company's growth story is one of contrasts. It is successfully expanding its business in terms of sales, operating profits, and total assets, which indicates strong market demand and a commitment to future expansion. However, this top-line growth is not filtering down to the bottom line. Shareholder earnings and net income are declining, suggesting that rising costs, interest expenses, or other factors are eroding profitability. This disconnect between business expansion and shareholder returns is a key concern.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 44.94 | 40.86 | 0.73 | 12.59 | 10.8 |
| Operating Profit Growth Rate | 35.94 | 28.74 | -1.79 | 23.64 | 0.74 |
| Earnings Per Share (EPS) Growth | 33.28 | 11.96 | -32.58 | -2.29 | -17.42 |
| Asset Growth Rate | 62.4 | 31.91 | 38.61 | 19.58 | 66.11 |
| Net Income Growth Rate | 45.16 | 11.11 | -28 | -2.78 | -17.14 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 37.26 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Platinum Industries Ltd | 8.59 | 24.08 | Neutral | 60.00 | 9.75 | 51.00 |
| 3 | Rossari Biotech Ltd | 8.46 | 17.69 | Neutral | 286.00 | 25.79 | 149.00 |
| 4 | Fineotex Chemical Ltd | 8.39 | 52.51 | Neutral | 135.00 | 0.79 | 125.00 |
| 5 | Excel Industries Ltd | 8.39 | 16.87 | Neutral | 110.00 | 58.39 | 76.00 |
| 6 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 36.16 | Neutral | 78.00 | 9.84 | 49.00 |
| 7 | Bhansali Engineering Polymers Ltd | 8.25 | 17.56 | Undervalued | 216.00 | 7.25 | 180.00 |
| 8 | Styrenix Performance Materials Ltd | 8.12 | 19.35 | Neutral | 463.00 | 180.10 | 273.00 |
| 9 | Balaji Amines Ltd | 7.71 | 46.70 | Overvalued | 265.00 | 51.09 | 169.00 |
| 10 | Tatva Chintan Pharma Chem Ltd | 7.13 | 89.27 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 11 | Neogen Chemicals Ltd | 6.69 | 197.61 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 12 | Yasho Industries Ltd | 6.09 | 203.81 | Neutral | 143.00 | 17.81 | 25.00 |
| 13 | Camlin Fine Sciences Ltd | 5.80 | 70.93 | Neutral | 107.00 | -1.72 | 24.00 |
| 14 | NOCIL Ltd | 5.27 | 50.94 | Neutral | 101.00 | 3.84 | 56.00 |
| 15 | Chemplast Sanmar Ltd | 4.81 | -9.62 | Neutral | 198.00 | -63.46 | -280.00 |
| 16 | Godavari Biorefineries Ltd | 4.15 | 340.51 | Neutral | 127.00 | 0.24 | 4.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Neogen Chemicals Ltd is a leading Indian manufacturer of Bromine-based and Lithium-based specialty chemicals. It develops and produces a diversified range of intermediates and advanced materials catering to pharmaceuticals, agrochemicals, engineering, and EV battery sectors. The company is also engaged in custom synthesis and contract manufacturing, holding a strong market position in its niche chemistries.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Neogen Chemicals Ltd's P/E ratio (TTM) is 125.59, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Neogen Chemicals Ltd's P/B ratio is 6.97, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Neogen Chemicals Ltd's P/S ratio is 6.85, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Neogen Chemicals Ltd's PEG ratio is -116.24.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Neogen Chemicals Ltd's EV/EBITDA ratio is 47.09.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Neogen Chemicals Ltd's ROE is 3.55%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Neogen Chemicals Ltd's ROA is 4.72%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Neogen Chemicals Ltd's ROCE is 6%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Neogen Chemicals Ltd's operating margin is 15.89%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Neogen Chemicals Ltd's net margin is 3.36%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Neogen Chemicals Ltd's current ratio is 1.31.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Neogen Chemicals Ltd's debt-to-equity ratio is 1.08.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Neogen Chemicals Ltd's interest coverage ratio is 1.55.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Neogen Chemicals Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Neogen Chemicals Ltd's EPS is -17.42.
(Source line: "Ratios as of 08 Oct 2026, based on last traded price of ₹2153.90. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1991
Headquarters: Navi Mumbai, Maharashtra
Core Offerings: Bromine Compounds, Lithium Compounds, Grignard Reagents, Organosilyl Chemicals, Custom Synthesis
Stock Listing: NSE (NEOGEN), BSE (542665)
Promoter: Harin Kanani & family
Incorporated in 1991, Neogen Chemicals began its operations focusing on Bromine-based specialty chemicals. Over the years, it expanded significantly into Lithium-based organic and inorganic compounds, Grignard reagents, and organosilyl compounds. The company emphasized R&D and capacity expansion, becoming a key supplier to pharmaceutical, agrochemical, and emerging EV battery industries. Neogen Chemicals successfully listed on Indian stock exchanges in 2019.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Bromine Chemistry | ~70% | N/A for specific segment |
| Lithium Chemistry | ~20% | N/A for specific segment |
| Custom Synthesis | ~10% | N/A for specific segment |
Bromine Chemistry: Manufactures a wide range of bromine-based intermediates and specialty chemicals used in pharmaceuticals, agrochemicals, construction, and electronics. Expertise in handling elemental bromine safely.
Lithium Chemistry: Produces lithium-based organic and inorganic chemicals, including advanced materials for lithium-ion batteries, serving the EV and energy storage sectors.
Custom Synthesis & Contract Manufacturing: Offers tailor-made chemical solutions and contract manufacturing services for complex molecules, leveraging strong R&D capabilities.
Mr. Harin Kanani - Chairman & Managing Director. A first-generation entrepreneur with over three decades of experience in the chemical industry, he founded Neogen Chemicals and has been instrumental in its growth trajectory.
Rights issue approved by the board on April 15, 2024, to raise up to ₹150 crore; proposed to issue 16,30,434 equity shares at ₹920 per share.
The Neogen Chemicals Ltd share price today is ₹2153.90 on NSE (NEOGEN), as of 08 Oct 2026.
As of 08 Oct 2026, Neogen Chemicals Ltd share price is ₹2153.90, with previous close ₹2153.90. Today's range is ₹2153.90 to ₹2153.90. The 52-week range is ₹N/A to ₹N/A.
As of today, Neogen Chemicals Ltd's market cap is ₹5,901.69 crore (Mid Cap).
Neogen Chemicals Ltd's current P/E ratio is 125.59, compared to the CHEMICALS & PETROCHEMICALS sector average of 33.
Neogen Chemicals Ltd's current P/B ratio is 6.97.
Neogen Chemicals Ltd's current dividend yield is N/A. Last dividend of ₹3.00 per share was declared on 15-May-2024.
Neogen Chemicals Ltd's EPS (TTM) is ₹-17.42.
Neogen Chemicals Ltd is a leading Indian manufacturer of Bromine-based and Lithium-based specialty chemicals. It develops and produces a diversified range of intermediates and advanced materials catering to pharmaceuticals, agrochemicals, engineering, and EV battery sectors. The company is also engaged in custom synthesis and contract manufacturing, holding a strong market position in its niche chemistries.
Neogen Chemicals Ltd is promoted by Harin Kanani & family, holding 51.23% as of 08 Oct 2026.
Neogen Chemicals Ltd is listed on NSE (NEOGEN) and BSE (542665). Its next quarterly results are expected on October 2024 (Q2 FY25).
Adjusted Earnings Per Share (Adjusted EPS)
Return on Assets (ROA)